Krishna Institute of Medical Sciences Limited (NSE:KIMS)
India · Delayed Price · Currency is INR 726.00
-0.15 (-0.02%)
Nov 12, 2026, 3:29 PM IST
NSE:KIMS Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 290,501 | 248,686 | 255,929 | 164,797 | 112,155 | 110,694 | |
Market Cap Growth | 8.31% | -2.83% | 55.30% | 46.94% | 1.32% | - |
Enterprise Value | 325,050 | 282,411 | 275,658 | 176,030 | 117,314 | 107,850 |
Last Close Price | 726.15 | 621.50 | 639.60 | 411.85 | 280.29 | 276.64 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 138.89 | 103.02 | 66.56 | 53.16 | 33.35 | 33.27 |
Forward PE | 68.06 | 63.26 | 57.37 | 43.29 | 30.55 | 30.33 |
PS Ratio | 6.31 | 6.37 | 8.43 | 6.60 | 5.10 | 6.71 |
PB Ratio | 6.82 | 9.72 | 10.58 | 7.87 | 5.79 | 7.85 |
P/TBV Ratio | 8.19 | 13.43 | 14.78 | 11.32 | 8.74 | 8.71 |
P/FCF Ratio | - | - | - | - | - | 72.02 |
P/OCF Ratio | 50.78 | 48.69 | 43.99 | 31.62 | 25.96 | 34.16 |
PEG Ratio | 1.57 | 2.55 | 1.71 | 1.61 | 0.89 | 0.65 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 7.06 | 7.23 | 9.08 | 7.05 | 5.34 | 6.53 |
EV/EBITDA Ratio | 36.60 | 37.39 | 36.54 | 28.40 | 20.13 | 21.07 |
EV/EBIT Ratio | 63.75 | 54.22 | 45.46 | 35.84 | 24.67 | 24.12 |
EV/FCF Ratio | - | - | - | - | - | 70.17 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.83 | 1.66 | 1.06 | 0.65 | 0.35 | 0.18 |
Debt / EBITDA Ratio | 4.00 | 5.34 | 3.30 | 2.15 | 1.13 | 0.50 |
Debt / FCF Ratio | - | - | - | - | - | 1.67 |
Net Debt / Equity Ratio | 0.74 | 1.64 | 1.03 | 0.59 | 0.28 | 0.05 |
Net Debt / EBITDA Ratio | 3.72 | 5.54 | 3.29 | 1.97 | 0.93 | 0.13 |
Net Debt / FCF Ratio | -4.14 | -4.56 | -5.81 | -9.70 | -3.82 | 0.43 |
Asset Turnover | 0.59 | 0.58 | 0.63 | 0.74 | 0.91 | 0.99 |
Inventory Turnover | 18.60 | 19.78 | 21.39 | 22.02 | 22.18 | 22.07 |
Quick Ratio | 0.78 | 0.55 | 0.61 | 1.00 | 1.36 | 1.57 |
Current Ratio | 1.05 | 0.76 | 0.83 | 1.21 | 1.61 | 1.83 |
Return on Equity (ROE) | 5.77% | 9.72% | 18.39% | 16.67% | 21.85% | 30.07% |
Return on Assets (ROA) | 4.07% | 4.83% | 7.91% | 9.04% | 12.26% | 16.72% |
Return on Invested Capital (ROIC) | 4.94% | 6.49% | 10.97% | 12.38% | 18.12% | 28.21% |
Return on Capital Employed (ROCE) | 6.70% | 8.00% | 12.40% | 14.40% | 18.00% | 26.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.72% | 0.97% | 1.50% | 1.88% | 3.00% | 3.00% |
FCF Yield | -2.61% | -3.69% | -1.67% | -0.77% | -1.27% | 1.39% |
Buyback Yield / Dilution | -1.53% | - | - | - | -0.74% | -4.32% |